BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32216225)

  • 1. [Pelvic MRI combined with TRUS-guided transperineal template mapping biopsy for the diagnosis of prostate cancer].
    Li Q; Xie JJ; Cao WZ; Deng JP; Liu C; Cui Y; Shao Q; Shen H
    Zhonghua Nan Ke Xue; 2019 May; 25(5):408-413. PubMed ID: 32216225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MRI/TRUS cognitive fusion combined with 12-core systematic transperineal prostate biopsy for the diagnosis of clinically significant prostate cancer: A report of 208 cases].
    Fu ZY; Sun LG; Zhang G; Gu YF; Bei ML; Hu J; Chen YC; Zhang J
    Zhonghua Nan Ke Xue; 2021 May; 27(5):421-425. PubMed ID: 34914317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications of transperineal template-guided prostate mapping biopsy].
    Wang F; Ding XF; Xu JN; Xu YZ; Zhou YQ; Luan Y; Lu SM; Tao HZ
    Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(6):428-431. PubMed ID: 30786336
    [No Abstract]   [Full Text] [Related]  

  • 4. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
    Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
    Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
    Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.
    Bittner N; Merrick G; Taira A; Bennett A; Schattel A; Butler W; Galbreath R; Adamovich E
    Am J Clin Oncol; 2018 Aug; 41(8):723-729. PubMed ID: 27906722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
    Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH
    Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies.
    Nafie S; Pal RP; Dormer JP; Khan MA
    World J Urol; 2014 Aug; 32(4):971-5. PubMed ID: 24337167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Transrectal Ultrasound Guided Biopsy Versus Transperineal Template Biopsy of the Prostate in Diagnosing Prostate Cancer in Men with Previous Negative Transrectal Ultrasound Guided Biopsy.
    Nafie S; Wanis M; Khan M
    Urol J; 2017 Mar; 14(2):3008-3012. PubMed ID: 28299763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.
    Choi YH; Kang MY; Sung HH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Kim CK; Park BK; Lee HM
    Clin Genitourin Cancer; 2019 Feb; 17(1):e19-e25. PubMed ID: 30415878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transperineal prostate biopsy guided by dynamic intracavitary three-dimensional contrast-enhanced tomographic ultrasound imaging].
    Chen M; Huang NJ; Lai ZH; Lü GR; Zhou JG; Chen XY
    Zhonghua Nan Ke Xue; 2019 Oct; 25(10):896-900. PubMed ID: 32233220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
    Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
    J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer.
    Pepe P; Garufi A; Priolo G; Pennisi M
    Clin Genitourin Cancer; 2017 Feb; 15(1):e33-e36. PubMed ID: 27530436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
    Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
    Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.
    Bittner N; Merrick GS; Stewart R; Andreini H; Taubenslag W; Curtis R; Butler WM; Wallner KE
    Urol Oncol; 2011; 29(4):398-404. PubMed ID: 19945303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection.
    Merrick GS; Tennant A; Fiano R; Bennett A; Anderson R; Galbreath R; Butler WM; Adamovich E
    World J Urol; 2020 Feb; 38(2):361-369. PubMed ID: 31020423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers.
    Volkin D; Turkbey B; Hoang AN; Rais-Bahrami S; Yerram N; Walton-Diaz A; Nix JW; Wood BJ; Choyke PL; Pinto PA
    BJU Int; 2014 Dec; 114(6b):E43-E49. PubMed ID: 24712649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TRUS-guided transperineal biopsy with 9 + X method for the diagnosis of prostate carcinoma: retrospective analysis of 420 cases].
    Yang WZ; Cui ZY; Zhang W; Zhou HY; Wang QS; Zhang YQ; Shi XQ
    Zhonghua Nan Ke Xue; 2010 Jul; 16(7):627-30. PubMed ID: 20873598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.